Download Unicorn Signals App

By EquityPandit

MARKETS

Neogen Chemicals Shares Rise 7% on Report of Technology Partnership with Major Japanese Firm

Neogen Chemicals shares rose on latest acquisition worth Rs 25 crore.

Shares of Neogen Chemicals rose nearly 7% in morning trade on April 10 after a report that the company may announce a technology transfer arrangement with a large Japanese conglomerate.

The company has reportedly scheduled a press conference for 3:30 pm, where an announcement about the arrangement may be made.

The stock reacted positively to the news, touching an intraday high of Rs 1,445. Shares of Neogen Chemicals were trading at Rs 1,433 on the National Stock Exchange at 12:18 am, up 6% from the previous close.

According to a report by ET-NOW, the arrangement will be used to manufacture lithium electrodes under the government’s Product-Linked Incentive (PLI) scheme. The company is also expected to provide detailed steps to manufacture electrolytes for lithium-ion batteries at its press conference.

The report also said the chemical company might manufacture lithium electrodes domestically for Ola Electric, Exide and Amaron.

The demand for lithium-ion batteries has been growing rapidly, not least due to the growing demand for electric vehicles. Most EV makers have been importing lithium-ion batteries to manufacture EVs for the domestic market. As such, the company’s investors welcomed news of Neogen’s foray into the space.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

Nifty Closes Below 22,800 for the First Time Since June 2024

Dhruva Kulkarni

Benchmark index Nifty slipped below 22,800 for the first time since June 2024, as foreign outflows persisted amid US tariff concerns.

The broader market saw a pullback, with midcaps ending their two-day relief rally. All sectoral indices, except Nifty Metal, closed in the red, with Nifty Auto leading losses, dragged down by M&M. The Nifty Auto index has now closed in the red 11 times in the last 13 sessions.

The Sensex fell 424.90 points to 75,311.06, while the Nifty dropped 117.25 points to 22,795.90. The Nifty Bank index lost 353.35 points to close at 48,981.20, and the Nifty Midcap 100 index declined 677.60 points, settling at 50,486.20.

Religare surged over 18% as the Burman family took control, while metal stocks like Tata Steel gained on positive management commentary. 

PSU banks faced profit booking, with PNB and IDBI Bank falling nearly 2% each. M&M plunged 7%, marking its steepest drop in seven months. REC and PFC ended in the red after reports of a possible government bailout.

Market breadth was weak, with declines outpacing advances at a 1:2 ratio.

Benchmark indices posted their second consecutive weekly loss, though midcaps outperformed. Auto and pharma stocks struggled due to concerns over potential US tariff hikes, while Nifty FMCG fell nearly 2% on worries about a consumption slowdown.

This week, nifty Metal gained over 5%, driven by optimism about a possible new US-China trade deal. M&M posted its worst weekly decline in nearly three years, falling over 9%, while Bharti Airtel and TCS were among the top Nifty losers.

In the midcap segment, Bharat Dynamics, Coforge, and Biocon led the losers, while Shriram Finance, NTPC, and Hindalco were the top Nifty gainers. APL Apollo, JSW Infra, and NMDC emerged as the biggest midcap winners.

Got Stock Related Questions? The Analyst is Ready.

Tired of missing hot stocks? Unicorn Signals provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!

MARKETS

Can Fin Homes Picks IBM India as System Integrator in Rs 296.95 Crore Deal, Shares Fall 1.5%

Dhruva Kulkarni

Shares of Can Fin Homes Ltd fell 1.5% after touching the day’s high of Rs 621.25 on 21st February, despite the firm announcing that it has selected IBM India Private Ltd to supply and maintain its core business solution for approximately Rs 297 crore.

The firm’s board approved IBM India as the system integrator for its core business solution, infrastructure, and security upgrades.

IBM will manage Lending Solutions, including the Loan Origination System (LOS), Loan Management System (LMS) with Collections, Document Management System (DMS), and Borrowing & Investment.

The company awarded IBM a seven-year contract, divided into 12 months of implementation, three months of warranty, and five years and nine months of support and maintenance.

The contract includes an optional two-year extension if mutually agreed upon, as per Can Fin Homes’ filing on 21st February.

The total contract value is Rs 296.95 crore for the seven years.

For Q3 FY25, Can Fin Homes’ net profit rose 6% YoY to Rs 212 crore, while Net Interest Income (NII) grew 4.3% YoY to Rs 350.4 crore.

At 1:54 PM, the shares of Can Fin Homes were trading 1.34% lower at Rs 596.95 on NSE.

Can Fin Homes Insights? Let the Analyst Guide You.

Ready to invest like a pro? Unicorn Signals app equips you with 100+ Free tools and knowledge you need to succeed. Download the Unicorn Signals app and gain access to daily stock lists and insightful market analysis and much more!

MARKETS

Religare Enterprises Shares Skyrocketed 9% as Burman Family Acquires Majority Stake 

Ali Waghbakriwala

Shares of Religare Enterprises Ltd skyrocketed 9% on 21 February after the Burman family became the company’s promoters and acquired the majority of the company.

This comes after the Burmans’ open offer of Rs 2,116 crore to buy an additional 26% of Religare Enterprises was met with a mediocre response. Only 0.07% of the 26% portion that was up for grabs was actually tendered, based on the data from the open offer.

Despite the lacklustre open offer, the Burman Group held 25.16% of Religare Enterprises.

The company issued a statement saying, “We are pleased to announce that we have acquired control of Religare Enterprises  and been designated as its promoters. We are grateful to our regulators, shareholders and other stakeholders for their trust and confidence.”

The group’s top priorities were stressed, such as establishing stability, enhancing governance, and promoting sustainable growth within the company. “Our vision for REL is anchored in governance, trust, and integrity, guiding us towards a future built on resilience and maximising stakeholder value,” the spokesperson said. 

Through four businesses, Finmart Pvt Ltd, Puran Associates Pvt Ltd, VIC Enterprises Pvt Ltd, and Milky Investment & Trading Company, the Burmans held a 20.15% stake in Religare Enterprises.

In September 2023, REL shareholders received an open offer from the Burman family, who own Dabur India and other businesses, including Eveready Industries, for Rs 2,116 crore to purchase up to a 26% stake in the company.

In January 2024, four companies also paid Rs 277 crore for a 3.6% share in the company through open market transactions.  The shares were bought by three Burman family businesses: Puran Associates, VIC Enterprises, and M B Finmart.

At 1:43 pm, the shares of Religare Enterprises were trading 6.16% higher at Rs 236.75 on NSE.

Religare Enterprises Insights? Let the Analyst Guide You.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

MARKETS

Senores Pharma Jumps 6% as Subsidiary Signs Roflumilast Acquisition Deal

Dhruva Kulkarni

Shares of Senores Pharmaceuticals Ltd surged 6% to hit the day’s high of Rs 565 on 21st February after its subsidiary signed an agreement to acquire the Abbreviated New Drug Application (ANDA) for Roflumilast 250 mcg and 500 mcg tablets.

Roflumilast is used to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations in patients with severe COPD linked to chronic bronchitis and a history of flare-ups.

The market size of Roflumilast in the US stood at $32 million as of MAT June 2024 and grew to $46 million by MAT September 2024, according to the filing.

Swapnil Shah, Managing Director of Senores Pharmaceuticals, stated that acquiring Roflumilast Tablet ANDA is a strategic move to strengthen their speciality distribution portfolio.

Roflumilast’s manufacturing will occur locally at Senores’ US site, ensuring better control over production and distribution.

This acquisition also marks the company’s entry into the chronic bronchitis therapy space, expanding its reach in respiratory care.

The move aligns with Senores’ strategy of identifying niche, under-penetrated generic formulations to address unmet healthcare needs.

At 12:43 PM, the shares of Senores Pharma were trading 4.19% higher at Rs 556.15 on NSE.

Stay Ahead with Senores Pharma. Ask the Analyst.

Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!

MARKETS

Tata Motors, M&M, Hyundai Shares Fall Up to 6% on EV Policy Buzz

Dhruva Kulkarni

Shares of automobile giants Tata Motors, M&M, and Hyundai Motor India fell 6% on 21st February amid reports that the government may ease EV import rules, paving the way for foreign players and intensifying competition for Indian automakers.

The development is crucial as Tesla has intensified efforts to enter the Indian market.

The government is considering lowering import duties and easing EV import norms to support Tesla’s entry.

Further duty relief may attract global EV makers and strengthen India’s role in the worldwide supply chain.

The Basic Customs Duty (BCD) on fully built EVs above $40,000 has been reduced to 70%, but a 40% Agriculture Infrastructure and Development Cess (AIDC) has been added.

The 10% Social Welfare Surcharge (SWS) has been removed, making the effective import duty 110% for EVs above $40,000.

For EVs priced below $40,000, the import duty remains unchanged at 70%.

At 11:55 AM, Hyundai Motor India was down 2.44% at Rs 1807.95, Tata Motors was down 1.93% at Rs 676.50, and M&M was down 5.42% at Rs 2685.50 on NSE.

Wondering About These Stocks? The Analyst Has Answers.

Tired of missing hot stocks? Unicorn Signals provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!

Latest
IPO
Weekly
Outlook

Stock
Market
Prediction